← Browse by Condition
Medical Condition

advanced metastatic solid tumors

Total Trials
3
Recruiting Now
3
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 1
NCT07274813 EARLY_Phase 1
Recruiting

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Enrollment
254 pts
Location
China
Sponsor
Shanghai Henlius Biotech
View Trial →
NCT05405595 Phase 1, Phase 2
Recruiting

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Enrollment
186 pts
Location
United States, China...
Sponsor
Adagene Inc
View Trial →
NCT07141706 Phase 1
Recruiting

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

Enrollment
233 pts
Location
United States, Austr...
Sponsor
DualityBio Inc.
View Trial →